Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF OPERATIONS

v3.8.0.1
STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
10 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Operating expenses:      
Research and development $ 1,707 $ 7,943 $ 2,468
Research and development - licenses acquired 2,337 12,433 6,079
General and administrative 254 11,409 2,816
Total operating expenses 4,298 31,785 11,363
Loss from operations (4,298) (31,785) (11,363)
Other income (expense)      
Interest income 0 505 16
Interest expense - related party (168) 0 (253)
Interest expense 0 (8) (895)
Change in fair value of derivative liabilities 0 0 (159)
Total other income (expense) (168) 497 (1,291)
Net Loss $ (4,466) $ (31,288) $ (12,654)
Net loss per common share outstanding, basic and diluted $ (0.45) $ (1.24) $ (1.15)
Weighted average number of common shares outstanding, basic and diluted 9,993,197 25,252,832 11,026,666